APA (7th ed.) Citation

TRJ, E., N, C., A, E., DJ, P., NH, T., D, H., . . . JS, L. (2026). A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms. British journal of cancer. https://doi.org/10.1038/s41416-026-03488-w

Chicago Style (17th ed.) Citation

TRJ, Evans, et al. "A First-in-human, Open-label Multicentre Phase 1 Study of the Orally Administered E7386 in Patients with Selected Advanced Neoplasms." British Journal of Cancer 2026. https://doi.org/10.1038/s41416-026-03488-w.

MLA (9th ed.) Citation

TRJ, Evans, et al. "A First-in-human, Open-label Multicentre Phase 1 Study of the Orally Administered E7386 in Patients with Selected Advanced Neoplasms." British Journal of Cancer, 2026, https://doi.org/10.1038/s41416-026-03488-w.